Anvisa warns of false advertisements about weight loss pens
The National Health Surveillance Agency (Anvisa) identified false advertisements, on social networks and on the internet, about the sale of GLP-1 agonist drugs, popularly known as weight-loss pens, including Mounjaro (tirzepatide). In